Bevacizumab Therapy of Neurofibromatosis Type 2 Associated Vestibular Schwannoma in Japanese Patients

We conducted a feasibility study to investigate the therapeutic effect of bevacizumab on vestibular schwannomas (VS) associated with neurofibromatosis type 2 (NF2) in a sample of Japanese patients. Ten NF2 patients were selected between 2013 and 2018: nine women and one man, with ages ranging from 1...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neurol Med Chir (Tokyo)
Hlavní autoři: FUJII, Masazumi, ICHIKAWA, Masahiro, IWATATE, Kensho, BAKHIT, Mudathir, YAMADA, Masayuki, KUROMI, Yosuke, SATO, Taku, SAKUMA, Jun, SAITO, Kiyoshi
Médium: Artigo
Jazyk:Inglês
Vydáno: The Japan Neurosurgical Society 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7040431/
https://ncbi.nlm.nih.gov/pubmed/31902875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2176/nmc.oa.2019-0194
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky